Financial Performance - Verra Mobility's Q1 2025 total revenue reached $223 million, a 6% year-over-year increase[6, 12] - Adjusted EBITDA for Q1 2025 was $95 million, representing a 3% year-over-year growth[6, 14] - Adjusted EPS for Q1 2025 was $030, an 11% year-over-year increase[6, 15] - Free Cash Flow for Q1 2025 was $42 million, a 108% year-over-year increase[6, 17] Segment Performance - Commercial Services revenue increased by 6% year-over-year, driven by increased travel volume, product adoption, and tolling activity[10, 25] - Government Solutions service revenue grew by 4% year-over-year, with 7% growth outside of New York City[10, 28] - Parking Solutions SaaS-only revenue grew 5% year-over-year, while total revenue remained flat due to a decline in installation and professional services[10, 31] Financial Outlook and Balance Sheet - The company reaffirmed its 2025 financial outlook, projecting total revenue between $925 million and $935 million[10, 40] - Adjusted EBITDA is expected to be between $410 million and $420 million, representing approximately 3% year-over-year growth[40] - Adjusted EPS is projected to be between $130 and $135, reflecting approximately 8% year-over-year growth[40] - Free Cash Flow is expected to be between $175 million and $185 million, with a conversion rate of approximately 43%[40] - As of March 31, 2025, Verra Mobility had $108 million in cash and cash equivalents and $75 million available under its revolving credit facility, resulting in $183 million in total available liquidity[33]

Q1 2025 Financial Results May 7, 2025 1 Safe Harbor Statement/Trademarks There are a number of important factors that could cause our actual results to differ materially from those indicated by such forward-looking statements, including, among others, the availability of USG funding for contracts related to procurement of our medical countermeasure ("MCM") products, including CYFENDUS® (Anthrax Vaccine Adsorbed (AVA) Adjuvanted), previously known as AV7909, and ACAM2000® (Smallpox (Vaccinia) Vaccine, Live), ...

Earnings Call Supplemental Slides First Quarter 2025 John Sabino, Chief Executive Officer John Collins, Chief Financial Officer and Chief Operating Officer May 7, 2025 Disclaimer This presentation as well as the associated earnings release and earnings call contain and will contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. You can generally identify forward-looking statements by o ...

Q1 2025 INVESTOR PRESENTATION reported on May 7, 2025 Elevating Essential Products Leading producer of specialty alcohols and high quality ingredients 1 Safe Harbor Statement Statements and information contained in this communication that refer to or include Alto Ingredients' estimated or anticipated future results or other non- historical expressions of fact are forward-looking statements that reflect Alto Ingredients' current perspective of existing trends and information as of the date of the communicati ...

Financial Performance - Net revenue decreased to $53 million in Q1 2025 from $67 million in Q1 2024 due to the planned exit of low margin business[10] - GAAP gross margin decreased to 25% in Q1 2025 from 73% in Q1 2024 due to Thailand to Singapore transition and decreased utilization[10] - Non-GAAP gross margin decreased to 108% in Q1 2025 from 134% in Q1 2024[10] - GAAP net loss from continuing operations improved to ($48 million) in Q1 2025 from ($54 million) in Q1 2024 due to reduction in strategic review costs[10] - Non-GAAP adjusted EBITDA was ($39 million) in Q1 2025 compared to ($32 million) in Q1 2024[10] Business Strategy and Outlook - The company is in "Execution Mode" of Perform-Accelerate-Transform (P-A-T) strategy[8] - The company expects Q2 2025 net revenue to be between $49 million and $53 million[12] - The company anticipates continued market uncertainty and is closely monitoring risks[7] - The company is transitioning RFID production to Thailand and expects to conclude Singapore-based production by the end of Q2 or shortly thereafter[8] - The company announced strategic partnerships with Tag-N-Trac for cold chain tracking solutions and is collaborating with InPlay on BLE-enabled smart labels[8]

EARNINGS PRESENTATION FIRST QUARTER 2025 May 7, 2025 LEGAL DISCLAIMERS Forward-Looking Information This presentation includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Alta's actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," " ...

Q1 2025 Financial Performance - Systemwide sales increased to $140.7 million, up 5% year-over-year[9] - Total revenue reached $109.0 million, a 1% increase compared to the previous year[9] - Franchise royalties, fees, and rent income grew significantly to $4.7 million, representing a 31% increase[9] - Same-store sales increased by 0.9%[9] - Adjusted EBITDA decreased by 3% to $5.5 million, negatively impacted by the absence of a $1.1 million legal settlement benefit from the previous year[9, 10] Shop-Level Profitability - Shop-level profit margin increased by 110 basis points to 13.7%[26, 43] - Average Weekly Sales (AWS) for company-operated shops was $24,550[24] Franchise Growth and Expansion - The Franchise Growth Acceleration (FGA) Initiative shows progress with 766 open and committed shops[34] - Additional franchise commitments increased by 19% year-over-year[35] Financial Outlook - Q2 2025 guidance projects same-store sales growth of 1.5% to 2.5% and adjusted EBITDA between $8.25 million and $9.75 million[38] - 2025 guidance anticipates at least 38 new shop openings and adjusted EBITDA between $33 million and $34 million[39]

Q1 2025 Q1 2025 Financial Highlights Q1 2025 Q1 2024 Revenue $24.4 million $30.7 million Adj. EBITDA1 $5.7 million $12.5 million Total Certs 27,638 28,189 (1) See reconciliation of GAAP to non-GAAP financial measures on page 5 2 23, 159, 221 149, 201, 61 20, 83, 150 Earnings Supplement 3, 102, 170 146, 192, 219 166, 166, 166 Key Performance Indicators | | | | Three Months Ended March 31, | | | --- | --- | --- | --- | --- | | | | 2025 | | 2024 | | Certs | | | | | | Credit Union & Bank | | 24,215 | | 21,078 | ...

Investor Strategic Update 2025 As of May 7, 2025 Forward Looking Statements This presentation contains certain forward-looking statements within the meaning of the federal securities laws, including statements about the outlook of our business and industry and other matters referenced in our earnings release and SEC filings. All statements other than statements of historical fact contained in this presentation, including statements on our business strategy, plans, objectives, financial results, operating re ...

H&R BLOCK Q3 FY25 Financial Results Conference Call Q3 FY25 Financial Results Conference Call May 7, 2025 H&R BLOCK Q3 FY25 Financial Results Conference Call Jordyn Eskijian Program Manager, Investor Relations & ESG H&R BLOCK Q3 FY25 Financial Results Conference Call Safe Harbor Statement Forward-Looking Statement This presentation contains forward-looking statements within the meaning of the securities laws. Forward-looking statements can be identified by the fact that they do not relate strictly to histor ...